← Back to Search
Rhamnose‐coated Superparamagnetic Iron‐oxide Nanoparticles: An Evaluation Of Their In Vitro Cytotoxicity, Genotoxicity And Carcinogenicity
Alessandro Paolini, C. P. Guarch, David Ramos-López, J. Lapuente, A. Lascialfari, Y. Guari, J. Larionova, J. Long, R. Nano
Published 2016 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
Tumor recurrence after the incomplete removal of a tumor mass inside brain tissue is the main reason that scientists are working to identify new strategies in brain oncologic therapy. In particular, in the treatment of the most malignant astrocytic tumor glioblastoma, the use of magnetic nanoparticles seems to be one of the most promising keys in overcoming this problem, namely by means of magnetic fluid hyperthermia (MFH) treatment. However, the major unknown issue related to the use of nanoparticles is their toxicological behavior when they are in contact with biological tissues. In the present study, we investigated the interaction of glioblastoma and other tumor cell lines with superparamagnetic iron‐oxide nanoparticles covalently coated with a rhamnose derivative, using proper cytotoxic assays. In the present study, we focused our attention on different strategies of toxicity evaluation comparing different cytotoxicological approaches in order to identify the biological damages induced by the nanoparticles. The data show an intensive internalization process of rhamnose‐coated iron oxide nanoparticles by the cells, suggesting that rhamnose moiety is a promising biocompatible coating in favoring cells’ uptake. With regards to cytotoxicity, a 35% cell death at a maximum concentration, mainly as a result of mitochondrial damages, was found. This cytotoxic behavior, along with the high uptake ability, could facilitate the use of these rhamnose‐coated iron‐oxide nanoparticles for future MFH therapeutic treatments. Copyright © 2015 John Wiley & Sons, Ltd.
This paper references
Nanoscale Materials in Chemistry, Klabunde KJ (ed.)
KJ Klabunde (2001)
Synthesis of monodisperse iron oxide nanocrystals by thermal decomposition of iron carboxylate salts.
W. W. Yu (2004)
Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)
N. Singh (2010)
Cellular toxicity of inorganic nanoparticles: Common aspects and guidelines for improved nanotoxicity evaluation
S. Soenen (2011)
World Health Organization Classification of Tumors: Pathology and Genetics: Tumors of the Nervous System
P Kleihues (2000)
Treatment of recidivemalignant gliomas with temozolomide
L Sipos (2002)
[Treatment of recidive malignant gliomas with temozolomide].
L. Sipos (2002)
Chemical synthesis of magnetic nanoparticles.
T. Hyeon (2003)
Selective heat sensitivity of cancer cells. Biochemical and clinical studies.
R. Cavaliere (1967)
The effects of hyperthermia on the cytoskeleton: a review.
R. Coss (1996)
Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging.
A. Arbab (2003)
The promotion of humanmesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles
DM Huang (2009)
Crystalline, Shape, and Surface Anisotropy in Two Crystal Morphologies of Superparamagnetic Cobalt Nanoparticles by Ferromagnetic Resonance
M. R. Diehl (2001)
Modulation of cytotoxic and genotoxic effects of nanoparticles in cancer cells by external magnetic field
Jyoti Shaw (2014)
Barrier functionality and transport machineries of human ECV304 cells.
J. Barar (2010)
Governance of Nanotechnology and Nanomaterials: Principles, Regulation, and Renegotiating the Social Contract
George A. Kimbrell (2009)
Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells
X. Wu (2010)
The cytotoxicity of polycationic iron oxide nanoparticles: Common endpoint assays and alternative approaches for improved understanding of cellular response mechanism
C. Hoskins (2012)
NMR as evaluation strategy for cellular uptake of nanoparticles.
T. Orlando (2014)
Cellular effects of hyperthermia: relevance to the minimum dose for thermal damage
J. Lepock (2003)
Involvement of DMT1 +IRE in the transport of lead in an in vitro BBB model.
Q. Wang (2011)
Incorporation of Biomarker Assessment in Novel Clinical Trial Designs: Personalizing Brain Tumor Treatments
E. Galanis (2011)
Effect of surface charge on the cellular uptake of fluorescent magnetic nanoparticles
S. Kralj (2012)
Enhanced cellular uptake of aminosilane-coated superparamagnetic iron oxide nanoparticles in mammalian cell lines
X. Zhu (2012)
Nanoscale materials in chemistry
K. Klabunde (2001)
Magnetic Properties of Nanostructured Materials
O. Crisan (2005)
Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles.
A. Gupta (2005)
Nanoparticles in cancer therapy and diagnosis.
I. Brigger (2002)
Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.
C. W. Jung (1995)
Intrinsic peroxidase-like activity of ferromagnetic nanoparticles.
Lizeng Gao (2007)
Trypan Blue Dye Enters Viable Cells Incubated with the Pore-Forming Toxin HlyII of Bacillus cereus
S. Tran (2011)
Research strategies for safety evaluation of nanomaterials, part VIII: International efforts to develop risk-based safety evaluations for nanomaterials.
K. Thomas (2006)
Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class.
T. Kilic (2000)
A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging
A. Arbab (2005)
Carbon nanotubes in cancer theragnosis.
Vivek S Thakare (2010)
Classification and basic properties of contrast agents for magnetic resonance imaging.
C. Geraldes (2009)
Water-soluble rhamnose-coated Fe3O4 nanoparticles.
Lenaic Lartigue (2009)
Recent advances in iron oxide nanocrystal technology for medical imaging.
C. Corot (2006)
Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress
S. Naqvi (2010)
The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles.
D. Huang (2009)
Toxicity of therapeutic nanoparticles.
Melissa A. Maurer-Jones (2009)
Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia
A. Jordan (2001)
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
G. Oberdörster (2005)
Dilemmas in the reliable estimation of the in-vitro cell viability in magnetic nanoparticle engineering: which tests and what protocols?
C. Hoskins (2012)
Selective Heat Sensitivity of Cancer Cells
A. Rossi-Fanelli (1977)
Visualization of internalization of functionalized cobalt ferrite nanoparticles and their intracellular fate
V. B. Bregar (2013)
Selective heat sensitivity of cancer cells. Biochemical and clinical studies
R. Cavaliere (1967)
Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling.
Stefaan J.H. Soenen (2011)
Design strategies of hybrid metallic nanoparticles for theragnostic applications.
J. Gautier (2013)
W. Wick (2006)
Clinical results with Resovist: a phase 2 clinical trial.
P. Reimer (1995)
The reliability and limits of the MTT reduction assay for carbon nanotubes-cell interaction
L. Belyanskaya (2007)
Critical steps for induction of chromosomal aberrations in CHO cells heated in S phase.
R. Wong (1993)
Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives.
Ki Young Choi (2012)
Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes.
M. Fisichella (2009)
Cell cultures as tools in biopharmacy.
A. Braun (2000)
Water-dispersible sugar-coated iron oxide nanoparticles. An evaluation of their relaxometric and magnetic hyperthermia properties.
Lenaic Lartigue (2011)
High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates.
L. Josephson (1999)
Toxicology and clinical potential of nanoparticles
L. Yildirimer (2011)
Particle-induced artifacts in the MTT and LDH viability assays.
A. Holder (2012)
Oxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventions.
L. Freeman (2012)
The reliability and limits of theMTT reduction assay for
L Belyanskaya (2007)
nanotubes - cell interaction
A Braun (2000)
This paper is referenced by
Enhanced Antibacterial Activity of Se Nanoparticles Upon Coating with Recombinant Spider Silk Protein eADF4(κ16)
Tao Huang (2020)
Toxicological assessment of silica-coated iron oxide nanoparticles in human astrocytes.
Natalia Fernández-Bertólez (2018)
Are iron oxide nanoparticles safe? Current knowledge and future perspectives.
Vanessa Valdiglesias (2016)
Magnetite Nanoparticles Induced Fetal Skeletal Abnormalities , DNA Damage and Down regulation of Pax-1 and Tgfb 2 Genes in White Albino Rats
Haidan M. El-Shorbagy (2018)
Synthesis and Characterisation of Magnetic Nanoparticles in Medicine
A. Majid (2018)
Quantitative Measurement of Ligand Exchange with Small-Molecule Ligands on Iron Oxide Nanoparticles via Radioanalytical Techniques.
Kathleen Davis (2016)
Cellular and Molecular Toxicity of Iron Oxide Nanoparticles.
B. Laffon (2018)
Radioanalytical Methods for Characterization of the Surface Modification of Nanoparticles
K. Davis (2017)
Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity
L. S. Arias (2018)
Thermally responsive peptide coated superparamagnetic iron oxide nanoparticles for drug delivery
A. Majid (2017)
Fibrous shape underlies the mutagenic and carcinogenic potential of nanosilver while surface chemistry affects the biosafety of iron oxide nanoparticles
A. Gábelová (2017)